Biotech Stocks Post Their Second-Best Month of 2019 

(Bloomberg) -- Biotech stocks are on pace for their second-best month of the year with momentum revived by a return of M&A activity and early FDA approvals for highly anticipated drugs.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.